Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial
Purpose: Determine the prognostic and predictive significance of tumor associated antigen (TAA)-specific serum antibodies in melanoma patients of a large adjuvant vaccination phase III trial. Patients and methods: Serum IgG antibodies were measured against a panel of 43 antigens by a bead-based mult...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
12 February 2018
|
| In: |
OncoImmunology
Year: 2018, Jahrgang: 7, Heft: 6 |
| ISSN: | 2162-402X |
| DOI: | 10.1080/2162402X.2018.1428157 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1080/2162402X.2018.1428157
|
| Verfasserangaben: | Judith Michels, Natalia Becker, Stefan Suciu, Iris Kaiser, Axel Benner, Zeynep Kosaloglu-Yalcin, Sandrine Agoussi, Niels Halama, Michael Pawlita, Tim Waterboer, Stefan B. Eichmüller, Dirk Jäger, Alexander M.M. Eggermont & Inka Zörnig |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1694608220 | ||
| 003 | DE-627 | ||
| 005 | 20220818041802.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200415s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/2162402X.2018.1428157 |2 doi | |
| 035 | |a (DE-627)1694608220 | ||
| 035 | |a (DE-599)KXP1694608220 | ||
| 035 | |a (OCoLC)1341315202 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Michels, Judith |e VerfasserIn |0 (DE-588)1208343130 |0 (DE-627)1694609901 |4 aut | |
| 245 | 1 | 0 | |a Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial |c Judith Michels, Natalia Becker, Stefan Suciu, Iris Kaiser, Axel Benner, Zeynep Kosaloglu-Yalcin, Sandrine Agoussi, Niels Halama, Michael Pawlita, Tim Waterboer, Stefan B. Eichmüller, Dirk Jäger, Alexander M.M. Eggermont & Inka Zörnig |
| 264 | 1 | |c 12 February 2018 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 15.04.2020 | ||
| 520 | |a Purpose: Determine the prognostic and predictive significance of tumor associated antigen (TAA)-specific serum antibodies in melanoma patients of a large adjuvant vaccination phase III trial. Patients and methods: Serum IgG antibodies were measured against a panel of 43 antigens by a bead-based multiplex assay in 970 stage II melanoma patients of the EORTC18961 trial, evaluating adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation. Primary end point was relapse-free survival (RFS). Patients' sera at baseline, after 12 and 48 weeks of study treatment and at the last available time point (at recurrence/remission) were evaluated. Results: Prognostic clinical variables are gender, surgical confirmation of lymph node-negative status, Breslow thickness and ulceration of the primary. Prognostic spontaneous antibody responses were associated with a significant dismal (GM2, Rhod_E2, SSX2) or good prognosis (CyclinB1, SCYE1v1) for RFS, distant metastasis-free (DMFS) or overall survival (OS). Predictive spontaneous antibody responses based on significant interaction with treatment were RhodN p = 0.02, Rab38 p = 0.04 for RFS, RhodE2 p = 0.006, Recoverin p = 0.04 for DMFS and RhodE2 p = 0.003; Recoverin p = 0.04, NA17.A p = 0.04, for OS respectively. The subgroups of patients according to antibody responses for RFS were determined for RhodN sero-negative (n = 849, HR = 1.07, p = 0.6); RhodN sero-positive (n = 121,HR = 0.42, p = 0.01) and Rab38 sero-negative (n = 682, HR = 1.12, p = 0.42), Rab38 sero-positive (n = 288, HR = 0.65, p = 0.04) patients respectively. Conclusion: We identified prognostic serum antibody responses against TAA in stage II melanoma patients. A set of antibody responses correlated with a beneficial outcome for GM2 vaccination. | ||
| 650 | 4 | |a autoantibody | |
| 650 | 4 | |a ganglioside | |
| 650 | 4 | |a melanoma | |
| 650 | 4 | |a multiplex serology | |
| 650 | 4 | |a rhodopsin | |
| 700 | 1 | |a Becker, Natalia |d 1976- |e VerfasserIn |0 (DE-588)1019237287 |0 (DE-627)684599635 |0 (DE-576)357290283 |4 aut | |
| 700 | 1 | |a Suciu, Stefan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kaiser, Iris |e VerfasserIn |0 (DE-588)1108793193 |0 (DE-627)863988962 |0 (DE-576)475484770 |4 aut | |
| 700 | 1 | |a Benner, Axel |d 1959- |e VerfasserIn |0 (DE-588)106584686X |0 (DE-627)81687221X |0 (DE-576)425536602 |4 aut | |
| 700 | 1 | |a Kosaloglu-Yalcin, Zeynep |e VerfasserIn |4 aut | |
| 700 | 1 | |a Agoussi, Sandrine |e VerfasserIn |4 aut | |
| 700 | 1 | |a Halama, Niels |d 1977- |e VerfasserIn |0 (DE-588)13087325X |0 (DE-627)507228723 |0 (DE-576)251045706 |4 aut | |
| 700 | 1 | |a Pawlita, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Waterboer, Tim |e VerfasserIn |0 (DE-588)119305494X |0 (DE-627)1671578821 |4 aut | |
| 700 | 1 | |a Eichmüller, Stefan B. |d 1960- |e VerfasserIn |0 (DE-588)1025289226 |0 (DE-627)721986951 |0 (DE-576)37016704X |4 aut | |
| 700 | 1 | |a Jäger, Dirk |d 1964- |e VerfasserIn |0 (DE-588)1032507535 |0 (DE-627)738505323 |0 (DE-576)380074125 |4 aut | |
| 700 | 1 | |a Eggermont, Alexander M. M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zörnig, Inka |e VerfasserIn |0 (DE-588)1022346741 |0 (DE-627)716954850 |0 (DE-576)36517937X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t OncoImmunology |d Abingdon : Taylor & Franics, 2012 |g 7(2018,6) Artikel-Nummer e1428157, 10 Seiten |h Online-Ressource |w (DE-627)683365428 |w (DE-600)2645309-5 |w (DE-576)356728366 |x 2162-402X |7 nnas |a Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial |
| 773 | 1 | 8 | |g volume:7 |g year:2018 |g number:6 |g extent:10 |a Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial |
| 856 | 4 | 0 | |u https://doi.org/10.1080/2162402X.2018.1428157 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200415 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 1022346741 |a Zörnig, Inka |m 1022346741:Zörnig, Inka |d 910000 |d 910100 |e 910000PZ1022346741 |e 910100PZ1022346741 |k 0/910000/ |k 1/910000/910100/ |p 14 |y j | ||
| 998 | |g 1032507535 |a Jäger, Dirk |m 1032507535:Jäger, Dirk |d 910000 |e 910000PJ1032507535 |k 0/910000/ |p 12 | ||
| 998 | |g 1025289226 |a Eichmüller, Stefan B. |m 1025289226:Eichmüller, Stefan B. |d 140000 |d 60000 |e 140000PE1025289226 |e 60000PE1025289226 |k 0/140000/ |k 0/60000/ |p 11 | ||
| 998 | |g 119305494X |a Waterboer, Tim |m 119305494X:Waterboer, Tim |d 140000 |e 140000PW119305494X |k 0/140000/ |p 10 | ||
| 998 | |g 13087325X |a Halama, Niels |m 13087325X:Halama, Niels |d 910000 |d 910100 |e 910000PH13087325X |e 910100PH13087325X |k 0/910000/ |k 1/910000/910100/ |p 8 | ||
| 998 | |g 106584686X |a Benner, Axel |m 106584686X:Benner, Axel |d 50000 |e 50000PB106584686X |k 0/50000/ |p 5 | ||
| 998 | |g 1108793193 |a Kaiser, Iris |m 1108793193:Kaiser, Iris |d 910000 |e 910000PK1108793193 |k 0/910000/ |p 4 | ||
| 998 | |g 1019237287 |a Becker, Natalia |m 1019237287:Becker, Natalia |p 2 | ||
| 999 | |a KXP-PPN1694608220 |e 3623932957 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"role":"aut","given":"Judith","family":"Michels","display":"Michels, Judith"},{"display":"Becker, Natalia","family":"Becker","given":"Natalia","role":"aut"},{"display":"Suciu, Stefan","family":"Suciu","role":"aut","given":"Stefan"},{"given":"Iris","role":"aut","display":"Kaiser, Iris","family":"Kaiser"},{"family":"Benner","display":"Benner, Axel","given":"Axel","role":"aut"},{"given":"Zeynep","role":"aut","family":"Kosaloglu-Yalcin","display":"Kosaloglu-Yalcin, Zeynep"},{"role":"aut","given":"Sandrine","display":"Agoussi, Sandrine","family":"Agoussi"},{"role":"aut","given":"Niels","family":"Halama","display":"Halama, Niels"},{"family":"Pawlita","display":"Pawlita, Michael","role":"aut","given":"Michael"},{"display":"Waterboer, Tim","family":"Waterboer","given":"Tim","role":"aut"},{"role":"aut","given":"Stefan B.","display":"Eichmüller, Stefan B.","family":"Eichmüller"},{"family":"Jäger","display":"Jäger, Dirk","given":"Dirk","role":"aut"},{"given":"Alexander M. M.","role":"aut","display":"Eggermont, Alexander M. M.","family":"Eggermont"},{"role":"aut","given":"Inka","family":"Zörnig","display":"Zörnig, Inka"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 15.04.2020"],"origin":[{"dateIssuedDisp":"12 February 2018","dateIssuedKey":"2018"}],"title":[{"title":"Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial","title_sort":"Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial"}],"id":{"doi":["10.1080/2162402X.2018.1428157"],"eki":["1694608220"]},"recId":"1694608220","relHost":[{"language":["eng"],"part":{"year":"2018","volume":"7","text":"7(2018,6) Artikel-Nummer e1428157, 10 Seiten","extent":"10","issue":"6"},"titleAlt":[{"title":"Onco Immunology"}],"recId":"683365428","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2645309-5"],"issn":["2162-402X"],"eki":["683365428"]},"origin":[{"publisherPlace":"Abingdon ; Austin, Tex.","dateIssuedDisp":"2012-","dateIssuedKey":"2012","publisher":"Taylor & Franics ; Landes Bioscience"}],"note":["Gesehen am 13.12.2022"],"pubHistory":["1.2012 -"],"title":[{"title":"OncoImmunology","title_sort":"OncoImmunology"}],"disp":"Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trialOncoImmunology","type":{"bibl":"periodical","media":"Online-Ressource"}}],"name":{"displayForm":["Judith Michels, Natalia Becker, Stefan Suciu, Iris Kaiser, Axel Benner, Zeynep Kosaloglu-Yalcin, Sandrine Agoussi, Niels Halama, Michael Pawlita, Tim Waterboer, Stefan B. Eichmüller, Dirk Jäger, Alexander M.M. Eggermont & Inka Zörnig"]},"physDesc":[{"extent":"10 S."}]} | ||
| SRT | |a MICHELSJUDMULTIPLEXB1220 | ||